A 2012 feasibility study with 60 randomized individuals completing 8 weeks of therapy. Results suggests: “A significant difference, favoring CST, was noted by treatment group in mean headache hours per day 30 days post treatment (1.89 vs. 2.78, p=0.003). HIT-6 scores decreased significantly in both groups, but without a between-group difference at the last treatment visit. MIDAS scores improved in the CST, but not the LSSM group at 4 weeks post treatment. Headache intensity was reduced more in the CST compared with the LSSM group” Further protocol modifications needed to enhance future research of CST for migraines.
Research: J Mann, S Gaylord, K Faurot, C Suchindran, R Coeytaux, L Wilkinson, R Coble, P Curtis. “P02.55. Craniosacral therapy for migraine: a feasibility study”. BMC Complement Altern Med. 2012; 12(Suppl 1): P111.
2012 HIT-6 Questionnaire completed by twenty participants, experiencing migraines at least twice a month, while receiving six craniosacral treatments over the span of four weeks. Results of the questionnaire indicated that “Immediately after treatments and one month afterwards there was significant lowering in HIT-6 scorings compared with prior to treatment.”
2007-2008 study looks at whether Upledger-style craniosacral has any effect on health conditions treated in age ranges of neonates to 68 years old. Of 157 patients, “outcome by diagnostic groups suggested that UCST is particularly effective for patients with headaches and migraine, neck and back pain, anxiety and depression, and unsettled babies.”